Related references
Note: Only part of the references are listed.Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
Franziska Baenke et al.
MOLECULAR ONCOLOGY (2016)
An inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response
Aude De Gassart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
Michael Cerezo et al.
CANCER CELL (2016)
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
Michael P. Smith et al.
CANCER CELL (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation
Min Pan et al.
NATURE CELL BIOLOGY (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets et al.
CANCER CELL (2015)
Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
Jurre J. Kamphorst et al.
CANCER RESEARCH (2015)
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis
Souvik Dey et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
Jenny E. Hernandez-Davies et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova et al.
NATURE (2015)
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Annelien Verfaillie et al.
NATURE COMMUNICATIONS (2015)
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
Stefanie Riesenberg et al.
NATURE COMMUNICATIONS (2015)
A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification
Matteo Dugo et al.
ONCOTARGET (2015)
Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response
Carmela Sidrauski et al.
ELIFE (2015)
γCaMKII Shuttles Ca2+/CaM to the Nucleus to Trigger CREB Phosphorylation and Gene Expression
Huan Ma et al.
CELL (2014)
Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma
Pauline Ostyn et al.
CELL COMMUNICATION AND SIGNALING (2014)
Targeting glutamine transport to suppress melanoma cell growth
Qian Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1
Youngtae Jeong et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNFα
Michael P. Smith et al.
CANCER DISCOVERY (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
Epithelial-to-Mesenchymal Transition Activates PERK-eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress
Yu-xiong Feng et al.
CANCER DISCOVERY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Directed Phenotype Switching as an Effective Antimelanoma Strategy
Magali Saez-Ayala et al.
CANCER CELL (2013)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death
Jaeseok Han et al.
NATURE CELL BIOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
Jennifer Landsberg et al.
NATURE (2012)
Systematic classification of melanoma cells by phenotype-specific gene expression mapping
Daniel S. Widmer et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma
T. Strub et al.
ONCOGENE (2011)
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
Y. Cheli et al.
ONCOGENE (2011)
Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas
Sandy Giuliano et al.
CANCER RESEARCH (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
The MicroArray Quality Control (MAQC)-IIII study of common practices for the development and validation of microarray-based predictive models
Leming Shi et al.
NATURE BIOTECHNOLOGY (2010)
Fifteen-year quest for microphthalmia-associated transcription factor target genes
Yann Cheli et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
被撤回的出版物: Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma (Retracted Article. See vol 15, pg 3240, 2009)
Christina K. Augustine et al.
CLINICAL CANCER RESEARCH (2009)
Modeling genomic diversity and tumor dependency in malignant melanoma
William M. Lin et al.
CANCER RESEARCH (2008)
Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells
Jane Goodall et al.
CANCER RESEARCH (2008)
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Suzanne Carreira et al.
GENES & DEVELOPMENT (2006)
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
V. C. Gray-Schopfer et al.
BRITISH JOURNAL OF CANCER (2006)
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Keith S. Hoek et al.
PIGMENT CELL RESEARCH (2006)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress
M Boyce et al.
SCIENCE (2005)
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF
JY Du et al.
CANCER CELL (2004)
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress
HP Harding et al.
MOLECULAR CELL (2003)
Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α
C Koumenis et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
